Ownership history in STEMPOINT CAPITAL LP · 14 quarters on record
This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in ARCUTIS BIOTHERAPEUTICS INC (ARQT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 224,740 | -187,153 | -45.4% | 1.12% | $6.5M | $29.04 |
| 2025 Q3 | ADDED | 411,893 | +206,221 | +100.3% | 1.56% | $7.8M | $18.85 |
| 2025 Q2 | ADDED | 205,672 | +105,672 | +105.7% | 0.93% | $2.9M | $14.02 |
| 2025 Q1 | REDUCED | 100,000 | -340,073 | -77.3% | 0.01% | $42K | $15.64 |
| 2025 Q1 | REDUCED | 440,073 | -1,134,927 | -72.1% | 2.19% | $6.9M | $15.64 |
| 2024 Q4 | ADDED | 1,575,000 | +1,074,034 | +214.4% | 0.14% | $581K | $13.93 |
| 2024 Q4 | REDUCED | 500,966 | -1,277,352 | -71.8% | 1.74% | $7.0M | $13.93 |
| 2024 Q3 | ADDED | 1,778,318 | +1,528,318 | +611.3% | 4.95% | $16.5M | $9.30 |
| 2024 Q3 | REDUCED | 250,000 | -4,750,000 | -95.0% | 0.00% | $12K | $9.30 |
| 2024 Q2 | ADDED | 5,000,000 | +4,034,608 | +417.9% | 0.10% | $350K | $9.30 |
As of 2025 Q4 — sorted by position size